RNA vs TEAM · rev $22.6M vs rev $6.57B
Atrium Therapeutics, Inc. Common Stock (RNA) versus Atlassian Corp Plc (TEAM) — a side-by-side from cached financials, not a winner call.
Atrium Therapeutics, Inc. Common Stock (RNA) is a biotechnology company listed on NASDAQ.
Atlassian Corp Plc (TEAM) is a software - application company listed on NASDAQ. It is led by Mike Cannon-Brookes.
Latest reported RNA revenue for 2026-06-30 was $22.6M. Net income was -$36.8M. Revenue was up 15.3% from 2026-03-31 to 2026-06-30. RNA currently screens at market cap $217.5M.
Latest reported TEAM revenue for 2026-06-30 was $6.57B. Net income was -$53.8M. Revenue was up 26.0% from 2025-06-30 to 2026-06-30. TEAM currently screens at market cap $22.01B.
RNA currently screens at market cap $217.5M. TEAM currently screens at market cap $22.01B.
Not investment advice. Open the RNA and TEAM stock pages for the full models.
Not investment advice.